EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

theRNA: a curated knowledgebase of functional RNA therapeutics spanning diverse modalities and disease applications

Yifan Zhou, Yongfei Hu, Luowanyue Zhang, Tianqing Wu, Suiyang Peng, Censhan Lin, Zhongxing Wang, Zhongguo Zhou, Jian Zheng iD, Jian Ren iD, Zhixiang Zuo iD

Nucleic Acids Research · 2026

DOI: 10.1093/nar/gkaf1064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Yifan Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat…. Hauptthemen laut MEDLINE: Knowledge Bases, RNA, Databases, Nucleic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Development Program of China, Shenzhen Medical Research Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA therapeutics are transforming precision medicine, yet a dedicated resource for validated agents has been lacking. Here, we introduce theRNA (https://therna.renlab.cn/), the first comprehensive database of 6860 experimentally validated RNA therapeutics targeting 1310 diseases in human or animal models. Curated from 11 126 peer-reviewed studies, theRNA focuses exclusively on functional therapeutic RNAs, including messenger RNA, small interfering RNA, microRNA, long noncoding RNA, circular RNA, short hairpin RNA, antisense oligonucleotides, aptamers, and CRISPR-related RNAs. Each entry provides extensive annotations on delivery modalities, efficacy readouts, and clinical potential. A user-friendly interface enables rapid searching and interactive exploration. As the first dedicated database for functional RNA therapeutics, theRNA aims to accelerate therapy development and deepen mechanistic understanding of disease and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Knowledge BasesRNADatabases, Nucleic AcidHumansAnimalsRNA, Small InterferingMicroRNAsRNA, CircularPrecision MedicineAptamers, NucleotideOligonucleotides, AntisenseRNA, Long NoncodingRNA, Messenger

Substanzen

RNARNA, Small InterferingMicroRNAsRNA, CircularAptamers, NucleotideOligonucleotides, AntisenseRNA, Long NoncodingRNA, Messenger

Autor:innen und Institutionen

  • Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, School of Life Sciences, Sun Yat-sen University, Guangzhou 510060, China.
  • Department of Anesthesiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510060, China.

ORCID-Profile: Jian Zheng, Jian Ren, Zhixiang Zuo

Förderung

  • Development Program of China
  • Shenzhen Medical Research Fund
  • National Natural Science Foundation of China
  • Guangdong Esophageal Cancer Institute Science and Technology Program
  • Young Talents Program of Sun Yat-sen University Cancer Center

Zitieren

APA

Zhou, Y., Hu, Y., Zhang, L., Wu, T., Peng, S., Lin, C., Wang, Z., Zhou, Z., Zheng, J., Ren, J., & Zuo, Z. (2026). theRNA: a curated knowledgebase of functional RNA therapeutics spanning diverse modalities and disease applications. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1064

Vancouver

Zhou Y, Hu Y, Zhang L, Wu T, Peng S, Lin C, et al. theRNA: a curated knowledgebase of functional RNA therapeutics spanning diverse modalities and disease applications. Nucleic Acids Research. 2026. doi:10.1093/nar/gkaf1064

BibTeX
@article{Zhou2026,
  author = {Zhou, Yifan and Hu, Yongfei and Zhang, Luowanyue and Wu, Tianqing and Peng, Suiyang and Lin, Censhan and Wang, Zhongxing and Zhou, Zhongguo and Zheng, Jian and Ren, Jian and Zuo, Zhixiang},
  title = {theRNA: a curated knowledgebase of functional RNA therapeutics spanning diverse modalities and disease applications},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkaf1064}
}
Kostenlos starten →